International Medical Journal (ISSN:13412051)

Aim and Scope

Aim-

International Medical Journal ISSN: (13412051) is an international open-access journal publishes twelve times each year. The "International Medical Journal" is a peer-reviewed, monthly, online international research journal, which publishes original articles, research articles, review articles with top-level work from all areas of Medical Science Research and their application including Aetiology, bioengineering, biomedicine, cardiology, chiropody, ENT etc. Researchers in all Medical Science and Pharmacy fields are encouraged to contribute articles based on recent research. Journal publishes research articles and reviews within the whole field of Medical Science and Pharmacy Research, and it will continue to provide information on the latest trends and developments in this ever-expanding subject. International Medical Journal journal covers almost all disciplines of Medical Science and Pharmacy. Researchers and students of M.B.B.S, M.D., D.T.C.D., GYNE., M.S., M.Pharma, And PhD are requested to send their original research articles to International Medical Journal. Azerbaijan Medical Journal Gongcheng Kexue Yu Jishu/Advanced Engineering Science

Scope-

International Medical Journal ISSN: (13412051) is a peer-reviewed journal. The journal seeks to publish original research articles that are hypothetical and theoretical in its nature and that provide exploratory insights in the following fields but not limited to:

Anatomy Physiology Biochemistry Pharmacology
Pathology Forensic medicine Microbiology Community Medicine
Otorhinolaryngology Internal Medicine General Surgery Obstetrics and Gynecology
Radiology Pulmonary Medicine Dermatology and Venereal diseases Infectious Diseases
Anaesthesia Cancer research Neurosurgery Orthopedics

See More Scopes

Latest Journals
International Medical Journal
Journal ID : IMJ-01-12-2020-678
Total View : 455

Abstract : Third molar impactions and its sequelae is one of the commonest reasons for seeking dental treatment. This study aimed to investigate third molar impaction using a digital panorama. This was a retrospective study carried out from April 2017- March 2020. Panoramic analysis of all patients that presented for oral treatment and having impacted third molars were reviewed. A total of 2,021 panoramic were screened and 530 panoramas with impacted third molars selected. The classification of the third molars were based on Winter’s and Pell and Gregory’s classifications. Data was analyzed using IBM SPSS software version 25 for IOS (Armonk, NY: IBM Corp). A total of 2,021 panoramic x-rays were screened and 530 panoramas with impacted molars was selected giving a prevalence rate of 26.5%. The 530 patients had a total of 1,481 (69.8%) impacted third molars (n=2120 (530x4)). There are 298 males and 232 females with a M: F of 1.3:1. MeanSD age was (28.57.14) years. Age range 20-25 years had the highest cases of with 209 (39.4%) patients. Tooth number 48 was the most frequently impacted with 436 (29.4%) cases (n=1481). Mesioangular impaction was the commonest with 600 (40.5%) cases. The majority of the impacted third molars were in Class 2 ramus relationship (571 (38.6%)) and Level I dept (674 (45.5%)). Prevalence was high from the current study (26.5%) and mesioangular impactions was the commonest spatial relationship. Class 2 Level 1 was the most common ramus and dept relationships..
Full article
International Medical Journal
Journal ID : IMJ-26-11-2020-676
Total View : 378

Abstract : This study aims to evaluate diagnostic reference levels (DRLs) for nuclear medicine (NM) imaging studies in Jordan. The parameters of the current study obtained from different NM modalities conducted for adult patients imaging. The Administrated Activity (AA) of a radioactive substance (MBq) was collected from four hospitals specialized in nuclear medicine imaging at Amman City. According to ICRP recommendation, the established DRLs values obtained based on the 75th percentile of the AA values. The obtained results were compared with several international results. The DRLs' values for Jordan were located within the recommended range..
Full article
International Medical Journal
Journal ID : IMJ-26-11-2020-675
Total View : 491

Abstract : Cancer is one of the primary causes of deaths worldwide. Cervical cancer is one of the leading causes of cancer mortality, accounting for 17% of all cancer deaths among women aged between 30 and 69 years. Various inflammatory, premalignant and malignant lesions of cervix are known to occur. Screening for cancer is known to reduce mortality by early detection and treatment. Overexpression of epidermal growth factor receptor family is associated with aggressive biological behavior and metastatic potential with poor prognosis. In this prospective study, we will be discussing the role of HER-2/neu as a prognostic marker for premalignant and malignant cervical lesions. We studied 50 cases of premalignant and malignant lesions of the uterine cervix from September 2018 – August 2020. The specimens were received in 10% formalin which were fixed and stained by routine hematoxylin and eosin stains. Immunohistochemically stain using HER-2/neu monoclonal antibody marker was done on each one of them, all the cases showed grade 0 results as per 2014 ASCO/CAP guidelines. According to various studies conducted, Her2/neu expression in malignant uterine cervical carcinomas ranged from 0% to 100%. The reason for variation in expression of Her2/neu immunostain could possibly be due to small sample size, disparity in monoclonal antibody kits used as well as discrepancy in the procedure conducted. Therefore, studies with greater number of sample size are required in order to establish the prognostic significance of HER2/neu in pathogenesis of cervical cancers. Thus, to conclude, this oncogene may not be a future target for monoclonal antibody directed therapy for cervical cancer.
Full article
International Medical Journal
Journal ID : IMJ-25-11-2020-672
Total View : 334

Abstract :

Abstract— Depression is a disorder of mood resulting in the reduction of productivity, an increase of suicide risk, and decreasing quality of life. The pathogenesis of depression might be associated with interleukin 6 (IL-6) that increases among depressed patients. Serotonin selective reuptake inhibitors (SRRI) agents have been widely used for the treatment of depression, but no reference discussed the comparison of the level of IL-6 among patients who were treated with SSRI and non-SSRI. This study determines the difference in serum IL-6 level among depressed patients were treated with SSRI and non-SSRI antidepressants. A cross-sectional study among 79 (54 SSRI groups and 25 non-SSRI groups) participants who were diagnosed with depression, having the medication with an antidepressant for at least 1 month were performed. The subjects then asked for venous blood collection for the serum IL-6 level examination. The comparison of serum IL-6 level was analyzed using the Mann-Whitney U Test. Our results demonstrated that there are no significant differences in the demographic, clinical characteristics, and serum IL-6 level among SSRI compared to the non-SSRI group (p=0.605). in conclusion, there is no significant difference in serum IL-6 levels among SSRI-treated depression patients compared to the non-SSRI groups.

.
Full article
International Medical Journal
Journal ID : IMJ-23-11-2020-669
Total View : 456

Abstract : The COVID-19 pandemic has increased the relevance of remote and preventive diagnosis. In an age of social distancing and self-isolation, developing personalized COVID-19 self-testing and monitoring systems is an important area of healthcare. The aim of the study was to develop and apply methods for the automated study of the acoustic characteristics of COVID-19 cough to optimize early diagnosis and assessment of disease dynamics. The study was conducted by Acoustery project team (Russian Federation) and Astana Medical University (Republic of Kazakhstan). For training and validation of the algorithm, data from 70 people (35 without COVID-19 and 35 with confirmed COVID-19) were used. 2-3 cough episodes were recorded for each study participant. In total of 196 cough episodes were recorded. Moreover, cough acoustic patterns were analyzed by a pulmonologist. Acoustic criteria that are signs of COVID-19 were identified. The results of this study may contribute to the development of effective remote screening to COVID-19 and increase the effectiveness of government control of the spread of the SARS-COV2..
Full article

Our Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
//